CD244 represents a new therapeutic target in head and neck squamous cell carcinoma.
Agresta L, Lehn M, Lampe K, Cantrell R, Hennies C, Szabo S, Wise-Draper T, Conforti L, Hoebe K, Janssen EM.
Agresta L, et al. Among authors: janssen em.
J Immunother Cancer. 2020 Mar;8(1):e000245. doi: 10.1136/jitc-2019-000245.
J Immunother Cancer. 2020.
PMID: 32217758
Free PMC article.